Huron Consulting Group (NASDAQ:HURN) Releases FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 6.800-7.600 for the period, compared to the consensus EPS estimate of 6.950. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Huron Consulting Group Trading Up 16.4 %

Shares of HURN stock traded up $20.50 on Wednesday, hitting $145.83. The stock had a trading volume of 360,598 shares, compared to its average volume of 116,878. The firm has a market capitalization of $2.59 billion, a P/E ratio of 31.79 and a beta of 0.59. Huron Consulting Group has a 1 year low of $84.26 and a 1 year high of $153.77. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The company’s 50 day moving average price is $125.75 and its 200-day moving average price is $117.37.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.38. The company had revenue of $399.31 million for the quarter, compared to the consensus estimate of $380.62 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. Analysts anticipate that Huron Consulting Group will post 6.1 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Wedbush assumed coverage on Huron Consulting Group in a report on Monday, February 3rd. They set an “outperform” rating for the company. William Blair restated an “outperform” rating on shares of Huron Consulting Group in a report on Wednesday. StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Truist Financial reissued a “buy” rating and set a $165.00 price objective (up from $140.00) on shares of Huron Consulting Group in a report on Wednesday. Finally, Barrington Research upped their target price on shares of Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, Huron Consulting Group has an average rating of “Buy” and a consensus price target of $145.50.

Insider Transactions at Huron Consulting Group

In other news, Director James H. Roth sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $126.03, for a total transaction of $252,060.00. Following the transaction, the director now directly owns 48,534 shares of the company’s stock, valued at approximately $6,116,740.02. This trade represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John Mccartney sold 500 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.65, for a total transaction of $62,325.00. Following the transaction, the director now owns 56,688 shares of the company’s stock, valued at approximately $7,066,159.20. This represents a 0.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,584 shares of company stock valued at $1,067,539 over the last 90 days. 2.02% of the stock is owned by company insiders.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.